17 AAG for HSP90 Inhibition in Cancer - From Bench to Bedside

Publisher： Bentham Science Publishers

E-ISSN： 1875-5666|9|5|654-664

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.9, Iss.5, 2009-06, pp. : 654-664

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

From bench to bedside

By Eckelman W.C.   Vera D.R.  

Nuclear Medicine and Biology, Vol. 30, Iss. 8, 2003-11 ,pp. : 793-794

Elsevier

Access to resources Recommend Favorite

Interleukin-6 and its receptor: from bench to bedside

By Scheller Jürgen   Rose-John Stefan  

Medical Microbiology and Immunology, Vol. 195, Iss. 4, 2006-12 ,pp. : 173-183

Springer Publishing Company

Access to resources Recommend Favorite

Refractory celiac disease: from bench to bedside

By Malamut Georgia   Meresse Bertrand   Cellier Christophe   Cerf-Bensussan Nadine  

Seminars in Immunopathology, Vol. 34, Iss. 4, 2012-07 ,pp. : 601-613

Springer Publishing Company

Access to resources Recommend Favorite

Stroke Induced Immunodepression Syndrome: From Bench to Bedside

By  

Current Molecular Medicine, Vol. 9, Iss. 2, 2009-03 ,pp. : 195-202

Bentham Science Publishers

Access to resources Recommend Favorite

Hsp90 inhibitors as novel cancer chemotherapeutic agents

By Neckers L.  

Trends in Molecular Medicine, Vol. 8, Iss. 4, 2002-04 ,pp. : 55-61

Elsevier

Access to resources Recommend Favorite